-
2020
Progress in a Pandemic
- Nephron steps up to respond to COVID-19, seeking FDA approval to ramp up production
- Opened a CLIA-certified Diagnostics Lab and began COVID-19 testing for employees, families and businesses in the Midlands and across South Carolina
- Launched production of FDA approved hand sanitizer
- Broke ground on a historic $215M expansion, including a vaccine production facility
- Announced plans for a Kennedy Innovation Complex
- Received FDA approval of an Abbreviated New Drug Application (ANDA) for two new products – 0.9% Sodium Chloride IV Bags, and Ketorolac Tromethamine Injection Vials
-
2019
Innovation
- Opened in-house pharmacy for employees and their families
- Launched an educator program that employs over 860 local teachers
- Reached a total of 2000+ FTE and PTE employees
- Added 75,000 square feet of clean room manufacturing space
- Installed 4 new sterile BFS lines
-
2018
Expansion
- Released new opioid free alternatives
- Established free overnight delivery via UPS
- Reached a total of 900+ employees
- Launched a $12.5 million expansion
-
2017
Nephron is nationwide
- Nephron 503B Outsourcing Facility officially launched
- Became licensed in all 50 states
-
2016
Portable relief
- Budesonide 0.25mg and 0.5mg received ANDA approval
- National launch of the Pocket Neb
-
2015
We're approved
- After 16 long months, Nephron finally receives full FDA approval
-
2014
Nephron moves to South Carolina
- Nephron headquarters relocated from Orlando, FL to West Columbia, SC
- Nephron was certified a woman-owned and woman-controlled business by NWBOC (National Women Business Owners Corporation)
-
2013
Efficiency through automation
- The fabrication of the new palletizing systems for the lines at Nephron's South Carolina facility completed
-
2012
Relief, now OTC
- Sodium Chloride (hypertonic saline) 3% and 7% launched
- Nephron SC breaks ground
- Launch of our first OTC Medication Asthmanefrin
-
2011
A new economic driver for the Midlands
- Nephron announced that the company would locate its new operations in Lexington County.
- The $313 million investment is expected to generate 707 new jobs.
-
2010
Expanding our reach
- Albuterol 0.021% Inhalation Solution ANDA approved
- Nephron expands distribution facilities with the purchase of a warehouse in Phoenix, AZ
- Murray, KY warehouse expanded to 150,000 sq. ft.
-
2009
Fighting for a level playing field
- Bill Kennedy hearing before the US House of Representatives on H.R. 1706: Protecting Consumer Access to Generic Drugs Act of 2009
-
2008
A year of continued growth
- Manufacturing Facility Expansion: Construction of an additional formulation weigh suite and filling suite
- Addition of Rommelag BFS Machines to increase capacity by 18 million vials per month
-
2007
Improving efficiency and speed
- Ipratropium Bromide 0.5mg/ Albuterol Sulfate 3mg Inhalation Solution (DuoDose) ANDA approved
- Addition of a High Speed Single Vial Packaging Line - 35,000 vials per hour
- Advanced Processes and Quality Controls
-
2006
Keeping up with demand
- Nephron acquires its first pieces of Bosch high-speed packaging machinery
-
2005
Automation promotes accuracy
- Launched the Electronic Fill Weights - EBR Manager
-
2004
A breath of fresh air
- Albuterol 0.042% Inhalation Solution ANDA approved
-
2003
Amplifying production
- Addition of 4 Weiler 640 BFS machines increased capacity to 58 million vials per month
-
2002
Getting the word out
- Lou Kennedy comes on board and begins to build marketing sales force
-
2001
Swift growth
- Albuterol 0.5% Inhalation Solution ANDA approved
- Ipratropium Bromide 0.02% Inhalation Solution ANDA approved
- Expansion to 76,000 sq.ft.
- Addition of single vial, bar coded packaging
-
2000
Alleviating respiratory discomfort
- S2 Racepinephrine Inhalation Solution launched
-
1999
Helping patients breathe easy
- Applied for Albuterol 0.5% Inhalation Solution ANDA
-
1998
Outgrowing our space
- Nephron expanded operations to 56,000 sq. ft.
-
1997
Our first product approved
- Albuterol 0.083% Inhalation Solution ANDA approved